Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum]

Terao T, Ishida A, Kimura T, Yoshida M, Hara T. Neuropsychiatr Dis Treat. 2017;13:1441–1448.On page 1443, Results section, Patient disposition subheading, Figure S1, ‘Excluded from HAM-D analysis setC 69’ should have been ‘Excluded from HAM-D analysis setC 269...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Terao T, Ishida A, Kimura T, Yoshida M, Hara T
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/d12b18d138da44868132c01afdf4ec31
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d12b18d138da44868132c01afdf4ec31
record_format	dspace
spelling	oai:doaj.org-article:d12b18d138da44868132c01afdf4ec312021-12-02T00:22:07ZAssessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum]1178-2021https://doaj.org/article/d12b18d138da44868132c01afdf4ec312017-08-01T00:00:00Zhttps://www.dovepress.com/corrigendum-assessment-of-safety-and-efficacy-of-lamotrigine-over-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Terao T, Ishida A, Kimura T, Yoshida M, Hara T. Neuropsychiatr Dis Treat. 2017;13:1441–1448.On page 1443, Results section, Patient disposition subheading, Figure S1, ‘Excluded from HAM-D analysis setC 69’ should have been ‘Excluded from HAM-D analysis setC 269’.Read the original articleTerao TIshida AKimura TYoshida MHara TDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 13, Pp 2219-2220 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Terao T Ishida A Kimura T Yoshida M Hara T Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum]
description	Terao T, Ishida A, Kimura T, Yoshida M, Hara T. Neuropsychiatr Dis Treat. 2017;13:1441–1448.On page 1443, Results section, Patient disposition subheading, Figure S1, ‘Excluded from HAM-D analysis setC 69’ should have been ‘Excluded from HAM-D analysis setC 269’.Read the original article
format	article
author	Terao T Ishida A Kimura T Yoshida M Hara T
author_facet	Terao T Ishida A Kimura T Yoshida M Hara T
author_sort	Terao T
title	Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum]
title_short	Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum]
title_full	Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum]
title_fullStr	Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum]
title_full_unstemmed	Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum]
title_sort	assessment of safety and efficacy of lamotrigine over the course of 1-year observation in japanese patients with bipolar disorder: post-marketing surveillance study report [corrigendum]
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/d12b18d138da44868132c01afdf4ec31
work_keys_str_mv	AT teraot assessmentofsafetyandefficacyoflamotrigineoverthecourseof1yearobservationinjapanesepatientswithbipolardisorderpostmarketingsurveillancestudyreportcorrigendum AT ishidaa assessmentofsafetyandefficacyoflamotrigineoverthecourseof1yearobservationinjapanesepatientswithbipolardisorderpostmarketingsurveillancestudyreportcorrigendum AT kimurat assessmentofsafetyandefficacyoflamotrigineoverthecourseof1yearobservationinjapanesepatientswithbipolardisorderpostmarketingsurveillancestudyreportcorrigendum AT yoshidam assessmentofsafetyandefficacyoflamotrigineoverthecourseof1yearobservationinjapanesepatientswithbipolardisorderpostmarketingsurveillancestudyreportcorrigendum AT harat assessmentofsafetyandefficacyoflamotrigineoverthecourseof1yearobservationinjapanesepatientswithbipolardisorderpostmarketingsurveillancestudyreportcorrigendum
_version_	1718403829569945600

Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum]

Ejemplares similares